Pediatrix Therapeutics

📍 Shanghai, China👥 5 employees💰 Last funded Jul 2020
Pediatrix Therapeutics is a pediatrics-focused biotechnology company based in China. Our aspiration is to bring high quality, pediatric-friendly and affordable therapeutics and healthcare products to children and families, leveraging the global development and licensing partnerships to grow our product portfolio. With incomparable expertise in pediatric market in China, we strive to improve the overall clinical care and experience for Chinese pediatric patients. Pediatrix Therapeutics, a company jointly founded in 2021 by Eight Roads, F-Prime Capital, and Creacion Ventures, has already completed its Series A funding round. We have established offices in Shanghai and Beijing, and is currently building an R&D center in Hangzhou, to enhance R&D, manufacturing and commercialization efforts and provide advanced pediatric solutions in China.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Pediatrix Therapeutics?
Pediatrix Therapeutics has 1 investors on record on gritt.io.
When did Pediatrix Therapeutics last raise funding?
The most recent investment in Pediatrix Therapeutics recorded on gritt.io was in July 2020.
What industry is Pediatrix Therapeutics in?
Pediatrix Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Pediatrix Therapeutics based?
Pediatrix Therapeutics is headquartered in Shanghai, China.